Sophie Snitkovsky - Publications

Affiliations: 
2000 Harvard University, Cambridge, MA, United States 

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2002 Snitkovsky S, Young JA. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein. Virology. 292: 150-5. PMID 11878917 DOI: 10.1006/Viro.2001.1314  0.828
2001 Snitkovsky S, Niederman TM, Mulligan RC, Young JA. Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. Journal of Virology. 75: 1571-5. PMID 11152532 DOI: 10.1128/Jvi.75.3.1571-1575.2001  0.809
2000 Snitkovsky S, Niederman TM, Carter BS, Mulligan RC, Young JA. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. Journal of Virology. 74: 9540-5. PMID 11000224 DOI: 10.1128/Jvi.74.20.9540-9545.2000  0.792
1999 Boerger AL, Snitkovsky S, Young JA. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proceedings of the National Academy of Sciences of the United States of America. 96: 9867-72. PMID 10449786 DOI: 10.1073/Pnas.96.17.9867  0.303
1998 Snitkovsky S, Young JA. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein. Proceedings of the National Academy of Sciences of the United States of America. 95: 7063-8. PMID 9618539 DOI: 10.1073/Pnas.95.12.7063  0.78
Show low-probability matches.